Innoplexus welcomes Dr. Sven Niedner as the Chief Operating Officer and Juergen Raths, MD as Life Sciences Head

Addition of Dr. Sven Niedner and Juergen Raths, MD into the leadership team of Innoplexus as Chief operating officer and Life Sciences Head respectively. End Quote

(1888PressRelease) August 19, 2017 - Innoplexus announces the joining of two members in the leadership team, Dr. Sven Niedner as the Chief Operating Officer and Juergen Raths, MD as Life Sciences Head both effective from August 1st 2017.

Dr. Gunjan Bhardwaj, Founder & CEO and Gaurav Tripathi, CTO of Innoplexus discussing about the expertise that Dr. Sven Niedner and Juergen Raths, MD would bring to Innoplexus said: "Both add experience and understanding of how companies scale to bring value to customers in the life science sector.” Dr. Bhardwaj also added: "Dr. Niedner has been in senior leadership roles including CTO position at Namics AG and most recently as Director Information Technology at UNIVERSUM Group. He not only knows what large organizations expect, but also being in a delivery role himself, what kind of services are necessary to ensure the delivery excellence.

J. Raths, MD adds 30 years of leadership experience in big pharma, biotech, biopharma and life sciences domain. He has worked in functional areas from clinical development to commercial to general management and understands the industry and the needs that Innoplexus products are designed to fulfil.

Innoplexus Vision is to be recognized by our customers as leading provider of Artificial Intelligence based products offering best in class data crawling, aggregation, analysis and visualization solutions.

Innoplexus Mission is to enable our customers to succeed in the competitive market by delivering real time access to the full picture of relevant data. Innoplexus continuously develops its products to enable broader, deeper and faster insights and best-founded decision making.

The addition of Dr. S. Niedner and J.Raths, MD will help Innoplexus in realising it's vision and put Innoplexus on an accelerated growth path.”

Dr. Sven Niedner commenced his career as a project manager at the Deutsche Telekom before he moved into the CTO position at Namics AG. He served as the CIO of a Lufthansa subsidiary, where he introduced a big-data based recommender system. He was most recently the director of Information Technology, Universum Group GmbH (Fintech), since August 2015, recognized for introducing new tool chain and redesigning the development process. Being the director of IT, Dr. Niedner served as a senior consultant for Awamo GmbH (pro bono consulting, Fintech startup), mentoring the founders and management on end to end IT setup and planning.

Commenting on his role as Chief Operating Officer, Innoplexus AG, Dr. Niedner said: “I am excited to join [Innoplexus] such a dynamic, intercultural company in the AI business and I am impressed by the maturity of the products and the qualification of the people.I will work with the team to further develop the Innoplexus products and improve internal processes to enable further growth of the business. The challenge will be to balance stability and change such that reliable delivery and innovation will go hand in hand.” Sharing with us his reason for joining and vision for Innoplexus, Dr. Niedner added: “It is the unique combination of an international delivery team, a clearly focussed business model and determined investors. I am sure that Innoplexus will become the leading company for AI based crawling, aggregation, analysis and visualization of data. With our team we will be on the leading edge of technology, successfully serving several industries -- starting with pharma. Innoplexus' business will continue to grow as the young field of Artificial Intelligence will further develop and gain acceptance”

Juergen Raths, MD was the first client of Innoplexus a few years back in a previous role as CEO of Correvio, a privately held Swiss specialty pharma company. Before that, Jürgen has worked as Head of Critical Care Europe, where he built up the first pan European business unit at Eli Lilly, focused on providing highly specialized clinical customers such as interventional cardiologists and intensive care clinicians with innovative and best in class products, scientific and commercial services.

Jürgen also served as CEO of Swiss public biotech company Arpida and was as COO member of the management board of Paion AG, a German public pharma specialty company.

Upon being asked about his journey to Innoplexus from being a client to being the head of Life Sciences, Jürgen said:
"Being the first client of Innoplexus was a great experience. Innoplexus had a technology that we needed and they were ready to engage in developing a product for us. At the beginning, we had a vague idea of what we needed but we could not describe precisely all the features of the solution. Innoplexus was ready to engage in developing a solution and they got it done with and for us.

The simple concept: We work out with our clients how we can best help them to get their job done by using the products and solutions we offer still applies: the founders have instilled that culture in the company. I am happy to be part of a journey that helps turning data into relevant and actionable information ... ultimately for better patient outcomes."

###

space

Other Related Press Releases